India, Oct. 30 -- This Healthcare Stock, engaged in providing diagnostic and preventive healthcare services, including pathology testing, clinical chemistry, thyroid testing, specialised diagnostics, and preventive health check-ups through its laboratory network, fell 8.73 percent after the company reported weak September quarterly results with a 70.35 percent QoQ decrease in net profit.

With a market capitalization of Rs. 7,592.98 crores, the share of Thyrocare Technologies Limited has reached an intraday low of Rs. 470.20 per equity share, down nearly 8.73 percent from its previous day's closing price of Rs. 515.20. Since then, the stock has retreated and is currently trading at Rs. 477.05 per equity share.

Q2 FY27 Result Walkthroug...